Agenovir Corporation

Agenovir Corporation

Agenovir Corporation was a biotechnology company founded in 2014 which was acquired by Vir Biotechnology in 2018.

Agenovir Corporation was a developer of a platform intended to remove the financial and operational obstacles to help companies in scientific research and discovery for the production of new and emerging healthcare products.

Timeline

March 17, 2016
Agenovir Corporation raises a $10,600,000 series A round from Celgene, Data Collective and Lightspeed Venture Partners.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Agenovir Corporation Series A round, March 17, 2016
10,600,000
March 17, 2016
1 Result
Results per page:
Page 1 of 1

SBA Awards

SBA Award
Agency
Award Type
Amount (USD)
Date Awarded
AGENOVIR CORPORATION SBIR Phase I Award, January 2016
SBIR
149,972
January 1, 2016
1 Result
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.